W
CPRX

WealthCollab’s Catalyst Pharmaceutical CPRX Stock Holding History

WealthCollab’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.64K Buy
349
+222
+175% +$5.29K ﹤0.01% 586
2025
Q4 		$2.96K Buy
127
+88
+226% +$1.96K ﹤0.01% 834
2025
Q3 		$769 Hold
39
– – ﹤0.01% 937
2025
Q2 		$847 Hold
39
– – ﹤0.01% 904
2025
Q1 		$946 Hold
39
– – ﹤0.01% 844
2024
Q4 		$814 Hold
39
– – ﹤0.01% 835
2024
Q3 		$776 Hold
39
– – ﹤0.01% 845
2024
Q2 		$605 Hold
39
– – ﹤0.01% 829
2024
Q1 		$622 Hold
39
– – ﹤0.01% 834
2023
Q4 		$656 Buy
+39
New +$533 ﹤0.01% 853

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

WealthCollab's CPRX Position: Q1 2026 in Review

WealthCollab increased its Catalyst Pharmaceutical (CPRX) stake by 175% in Q1 2026, buying an estimated $5.29K and bringing the position to 349 shares worth $8.64K. The position accounts for ﹤0.01% of the portfolio, ranked #586.

WealthCollab first reported a position in CPRX in Q4 2023 and has held it in 10 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • WealthCollab held 349 shares of Catalyst Pharmaceutical worth $8.64K as of Q1 2026.
  • WealthCollab bought 222 Catalyst Pharmaceutical shares in Q1 2026, an estimated $5.29K.
  • Catalyst Pharmaceutical made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #586 holding.
  • WealthCollab first reported a position in Catalyst Pharmaceutical in Q4 2023 and has held it in 10 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.